In an adult patient with a positive rapid plasma reagin (RPR) test and a quantitative titer of 1 : 2, what is the appropriate diagnosis, confirmatory testing, and treatment plan?

Management of Positive RPR with 1:2 Titer

A reactive RPR at 1:2 requires immediate confirmatory treponemal testing (FTA-ABS, TP-PA, or T. pallidum IgG) before any treatment decision, and if confirmed positive, represents active syphilis requiring full treatment regardless of the low titer. 1

Diagnostic Confirmation

• Obtain treponemal antibody testing immediately (FTA-ABS, TP-PA, or T. pallidum IgG) because false-positive RPR results occur in pregnancy, autoimmune disease, acute viral illness, injection drug use, and malaria. 1, 2, 3

• A reactive treponemal test confirms prior or current Treponema pallidum exposure and indicates the need for treatment if no adequate prior therapy is documented. 1

• A non-reactive treponemal test indicates the RPR is a false-positive and no syphilis treatment is needed. 1, 2

• Do not dismiss a 1:2 titer as insignificant—even low titers represent active infection requiring full treatment in untreated patients. 1, 2

Clinical Staging (If Treponemal Test Confirms Syphilis)

Review the patient's history and perform a targeted physical examination to stage the infection:

• Primary syphilis: Look for a chancre or genital ulcer. 1

• Secondary syphilis: Examine for rash (especially palms/soles), mucous patches, condyloma lata, or generalized lymphadenopathy. 1

• Early latent syphilis: Asymptomatic infection acquired within the past 12 months based on history (e.g., prior negative test, known exposure timing, or documented seroconversion). 1

• Late latent or unknown-duration syphilis: Asymptomatic infection >12 months or timing cannot be determined. 1

• Document any prior syphilis diagnosis, treatment dates, regimens used, and previous RPR titers to contextualize current serology. 1

Treatment Recommendations

For Primary, Secondary, or Early Latent Syphilis

• Benzathine penicillin G 2.4 million units intramuscularly as a single dose. 4, 1

For Late Latent Syphilis or Syphilis of Unknown Duration

• Benzathine penicillin G 7.2 million units total, administered as three weekly intramuscular doses of 2.4 million units each. 4, 1

Penicillin Allergy (Non-Pregnant Patients)

• For early latent syphilis: Use alternatives recommended for primary/secondary syphilis (doxycycline 100 mg orally twice daily for 14 days). 4

• For late latent or unknown duration: Doxycycline 100 mg orally twice daily for 28 days OR tetracycline 500 mg orally four times daily for 28 days, with close serologic and clinical follow-up. 4

Pregnancy

• Penicillin is the only acceptable treatment during pregnancy; use the regimen appropriate for the woman's stage of syphilis. 4

• Pregnant women allergic to penicillin require desensitization followed by penicillin therapy. 4

Indications for CSF Examination

Perform lumbar puncture and CSF examination if any of the following apply:

• HIV-positive patients with late latent syphilis or syphilis of unknown duration (before initiating therapy). 4, 1

• Neurologic signs or symptoms (e.g., cranial nerve dysfunction, meningitis, stroke, altered mental status, loss of vibration sense). 4, 1

• Ophthalmic signs or symptoms (e.g., iritis, uveitis, visual changes). 4, 1

• Evidence of tertiary syphilis (aortitis, gumma). 4, 1

• Documented treatment failure (fourfold increase in titer or failure of initially high titer ≥1:32 to decline fourfold within 12-24 months). 4, 1

• Some specialists recommend CSF testing when the quantitative nontreponemal titer exceeds 1:32, though this is not universally required. 1

Follow-Up Monitoring

HIV-Negative Patients

• Repeat quantitative RPR at 6,12, and 24 months after treatment. 4, 1

• An adequate serologic response is a ≥4-fold decline in RPR titer (e.g., from 1:8 to 1:2 or from 1:2 to nonreactive) within 6-12 months. 1

• If titers increase fourfold, an initially high titer (≥1:32) fails to decline fourfold within 12-24 months, or signs/symptoms develop, perform CSF examination and consider retreatment. 4

HIV-Positive Patients

• Repeat quantitative RPR at 3,6,9,12,18, and 24 months after treatment. 4, 1

• If RPR titer does not decline ≥4-fold within 12-24 months, CSF examination is indicated. 4, 1

• Some HIV-infected patients may have atypical serologic responses (unusually high, low, or fluctuating titers) requiring closer monitoring. 4

Critical Pitfalls to Avoid

• Never assume a low titer (1:2) is clinically insignificant—it represents active disease requiring full treatment if treponemal testing confirms syphilis. 1, 2

• RPR titers can spontaneously fluctuate (increase or decrease more than fourfold) within 1-3 months even without treatment, so repeat testing on the day of treatment if delayed from diagnosis. 5, 6

• Interlaboratory variability in RPR testing can produce up to 3-fold differences in titers; use the same laboratory and same test method (RPR vs. VDRL) for serial monitoring. 4, 7

• Some patients remain "serofast" with persistently low RPR titers (1:1 to 1:4) after adequate treatment; this does not necessarily indicate treatment failure if titers are stable and no clinical signs are present. 4

• In ocular syphilis, up to 22% of patients may have nonreactive RPR despite active disease, so maintain high clinical suspicion based on eye findings and positive treponemal serology. 4, 8